The Network for Excellence in Health Innovation finds potential areas of innovation and then tries to eliminate the obstacles to those ideas so its members can achieve the triple aim, according to Susan Dentzer, president and CEO of The Network for Excellence in Health Innovation.
The Network for Excellence in Health Innovation finds potential areas of innovation and then tries to eliminate the obstacles to those ideas so its members can achieve the triple aim, according to Susan Dentzer, president and CEO.
Transcript (slightly modified)
What are your key goals as the new president and CEO of the Network for Excellence in Health Innovation?
So, at NEHI, Network for Excellence in Health Innovation, we really do take seriously this notion of innovation. We’re a policy institute, a think tank, sitting within a membership organization, and we look for ways to engage our broad membership — payers, providers, patient groups, biopharmaceutical companies, and others – in innovating, looking for areas where we could innovate around the triple aim, and then in particular, solving problems that get in the way of that innovation.
Taking the obstacles out, or at least beginning to understand what are the obstacles that stand in the way of innovation, whether they are inherent to systems or organizations or whether they’re related to policies at the federal, state, or local level. And then, identify what needs to happen to remove those obstacles and actually allow the innovations that have this amazing potential to improve health or improve care or create more sustainable costs, allow those to flourish.
So we are already engaged in activities that further those goals and we’ll be doing more and more of those in the future. Looking for ways where we can solve problems in healthcare by bringing the sectors together and brainstorming how we can achieve those results.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More